BG63815B1 - Използване на аминопуринови антивирусни средства за лечение и профилактика на латентни инфекции, причинени от херпесни вируси - Google Patents

Използване на аминопуринови антивирусни средства за лечение и профилактика на латентни инфекции, причинени от херпесни вируси Download PDF

Info

Publication number
BG63815B1
BG63815B1 BG101608A BG10160897A BG63815B1 BG 63815 B1 BG63815 B1 BG 63815B1 BG 101608 A BG101608 A BG 101608A BG 10160897 A BG10160897 A BG 10160897A BG 63815 B1 BG63815 B1 BG 63815B1
Authority
BG
Bulgaria
Prior art keywords
infection
treatment
compound
formula
administration
Prior art date
Application number
BG101608A
Other languages
Bulgarian (bg)
English (en)
Other versions
BG101608A (en
Inventor
Hugh FIELD
Alana THACKRAY
Teresa BACON
David Sutton
HODGE Richard VERE
Original Assignee
Smithkline Beecham P.L.C.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27451235&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BG63815(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GBGB9425012.3A external-priority patent/GB9425012D0/en
Priority claimed from GBGB9506663.5A external-priority patent/GB9506663D0/en
Priority claimed from GBGB9517308.4A external-priority patent/GB9517308D0/en
Application filed by Smithkline Beecham P.L.C. filed Critical Smithkline Beecham P.L.C.
Publication of BG101608A publication Critical patent/BG101608A/xx
Publication of BG63815B1 publication Critical patent/BG63815B1/bg

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BG101608A 1994-12-12 1997-06-12 Използване на аминопуринови антивирусни средства за лечение и профилактика на латентни инфекции, причинени от херпесни вируси BG63815B1 (bg)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GBGB9425012.3A GB9425012D0 (en) 1994-12-12 1994-12-12 Pharmaceuticals
GBGB9506663.5A GB9506663D0 (en) 1995-03-31 1995-03-31 Pharmaceuticals
GBGB9517308.4A GB9517308D0 (en) 1995-08-24 1995-08-24 Pharmaceuticals
US08/522,790 US5840763A (en) 1994-12-12 1995-09-01 Treatment of a latent infection of herpes viruses
PCT/EP1995/004692 WO1996018396A1 (en) 1994-12-12 1995-11-23 Use of aminopurine antiviral agents for the treatment and prophylaxis of latent herpesvirus infections

Publications (2)

Publication Number Publication Date
BG101608A BG101608A (en) 1998-02-27
BG63815B1 true BG63815B1 (bg) 2003-02-28

Family

ID=27451235

Family Applications (1)

Application Number Title Priority Date Filing Date
BG101608A BG63815B1 (bg) 1994-12-12 1997-06-12 Използване на аминопуринови антивирусни средства за лечение и профилактика на латентни инфекции, причинени от херпесни вируси

Country Status (24)

Country Link
US (2) US5840763A (ro)
EP (1) EP0799039B1 (ro)
JP (1) JP2008088189A (ro)
CN (1) CN1098687C (ro)
AP (1) AP669A (ro)
AT (1) ATE208198T1 (ro)
AU (1) AU699627B2 (ro)
BG (1) BG63815B1 (ro)
BR (1) BR9509986A (ro)
CA (1) CA2207503C (ro)
CY (1) CY2339B1 (ro)
CZ (1) CZ291545B6 (ro)
DE (1) DE69523776T2 (ro)
DK (1) DK0799039T3 (ro)
ES (1) ES2166834T3 (ro)
HK (1) HK1003259A1 (ro)
HU (1) HU222835B1 (ro)
NO (1) NO313862B1 (ro)
NZ (1) NZ297424A (ro)
PT (1) PT799039E (ro)
RO (1) RO120042B1 (ro)
SI (1) SI0799039T1 (ro)
SK (1) SK282983B6 (ro)
WO (1) WO1996018396A1 (ro)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5840763A (en) * 1994-12-12 1998-11-24 Smithkline Beecham Plc Treatment of a latent infection of herpes viruses
US6047209A (en) * 1999-04-02 2000-04-04 Denny; Jeffrey Paul Method and apparatus for maintenance of pierced orifices
CA2602691A1 (en) * 2005-03-30 2006-10-05 Novartis Ag Penciclovir or famciclovir for the treatment of recurrent genital herpes with a one-day application
AU2006230269A1 (en) * 2005-03-30 2006-10-05 Novartis Ag Penciclovir or famciclovir for the treatment of recurrent genital herpes with a one-day application
US20100136106A1 (en) * 2005-06-08 2010-06-03 Gary Liversidge Modified Release Famciclovir Compositions
EP3753563A1 (en) * 2019-06-20 2020-12-23 Helmholtz-Zentrum für Infektionsforschung GmbH Anti-herpesvirus guanosine analogue for the inhibition of basal autophagy

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4355032B2 (en) * 1981-05-21 1990-10-30 9-(1,3-dihydroxy-2-propoxymethyl)guanine as antiviral agent
US4423050A (en) * 1981-05-21 1983-12-27 Syntex (U.S.A.) Inc. 9-(1,3-Dihydroxy-2-propoxymethyl)guanine as antiviral agent
US4461757A (en) * 1983-02-23 1984-07-24 Ens Bio Logicals Inc. Dimethylaminomethylenated anti-herpes compounds
DE3485225D1 (de) * 1983-08-18 1991-12-05 Beecham Group Plc Antivirale guanin-derivate.
GB9015051D0 (en) * 1990-07-07 1990-08-29 Beecham Group Plc Pharmaceutical treatment
US5840763A (en) * 1994-12-12 1998-11-24 Smithkline Beecham Plc Treatment of a latent infection of herpes viruses

Also Published As

Publication number Publication date
EP0799039B1 (en) 2001-11-07
SK282983B6 (sk) 2003-01-09
CY2339B1 (en) 2004-02-06
RO120042B1 (ro) 2005-08-30
AP9701001A0 (en) 1997-07-31
SK75197A3 (en) 1997-11-05
CZ179997A3 (en) 1997-09-17
WO1996018396A1 (en) 1996-06-20
DE69523776D1 (de) 2001-12-13
NO972688D0 (no) 1997-06-11
BR9509986A (pt) 1997-11-25
NZ297424A (en) 2000-07-28
CZ291545B6 (cs) 2003-04-16
HUT77437A (hu) 1998-04-28
JP2008088189A (ja) 2008-04-17
AU699627B2 (en) 1998-12-10
NO972688L (no) 1997-08-07
CN1098687C (zh) 2003-01-15
DE69523776T2 (de) 2002-08-01
NO313862B1 (no) 2002-12-16
CA2207503A1 (en) 1996-06-20
DK0799039T3 (da) 2002-01-28
HU222835B1 (hu) 2003-11-28
ATE208198T1 (de) 2001-11-15
PT799039E (pt) 2002-04-29
CA2207503C (en) 2006-07-18
EP0799039A1 (en) 1997-10-08
HK1003259A1 (en) 1998-10-23
AU4257896A (en) 1996-07-03
CN1175212A (zh) 1998-03-04
MX9704336A (es) 1997-09-30
US5840763A (en) 1998-11-24
SI0799039T1 (en) 2002-06-30
US5916893A (en) 1999-06-29
AP669A (en) 1998-09-04
BG101608A (en) 1998-02-27
ES2166834T3 (es) 2002-05-01

Similar Documents

Publication Publication Date Title
JP2008088189A (ja) 潜伏ヘルペスウイルス感染の治療および予防のためのアミノプリン抗ウイルス剤の使用
CZ234098A3 (cs) Farmaceutický výrobek
JP2007297412A (ja) ヒト・ヘルペスウイルス−８の治療に対するペンシクロビルの使用
RU2181049C2 (ru) Использование аминопуриновых противовирусных соединений для лечения и профилактики латентных инфекций, вызванных вирусом герпеса
AU696833B2 (en) Use of 2-amino purine derivatives for the treatment and prophylaxis of human herpes virus 7 infection
RU2293562C2 (ru) Использование аминопуриновых противовирусных соединений для лечения и профилактики латентных инфекций, вызванных вирусом герпеса
KR100382707B1 (ko) 잠재적허피스바이러스감염의치료및예방을위한아미노퓨린항바이러스제의용도
KR100341737B1 (ko) 인간헤르페스바이러스6감염의치료및예방용2-아미노푸린유도체의용도
MXPA97004336A (en) Use of antiviral agents for the treatment and prophylaxis of latent infections of herpesvi
US6683084B1 (en) Use of 2-amino purine derivatives for the treatment and prophylaxis of human herpes virus 6 infections
JPH10510278A (ja) 潜伏ヘルペスウイルス感染の治療および予防のためのアミノプリン抗ウイルス剤の使用
JPH09506883A (ja) 薬 剤
WO1998003176A1 (en) Treatment of feline infections peritonitis by an antiviral